EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway

Hongfa Wei, Wenchao Li, Leli Zeng, Ni Ding, Kuan Li, Hong Yu, Fei Jiang, Haofan Yin, Yu Xia, Cuncan Deng, Nan Cai, Xiancong Chen und 6 weitere

Molecular Cancer · 07.06.2024 · 23 (1)

DOI: 10.1186/s12943-024-02016-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cancer, online erschienen am 07.06.2024. Verfasst von Hongfa Wei und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping, Shantou, Guangdong, 515041, P.R. China. Hauptthemen laut MEDLINE: Metaplasia, Glycogen Synthase Kinase 3 beta, beta Catenin, Myosin Heavy Chains. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Key Laboratory of Digestive Cancer Research, Guangdong Basic and Applied Basic Research Foundation, the Science and Technology Planning Project of Shenzhen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal metaplasia (IM) is classified into complete intestinal metaplasia (CIM) and incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated susceptibility to the development of gastric cancer, underscoring the critical need for early screening measures. In addition to the complexities associated with diagnosis, the exact mechanisms driving the progression of gastric cancer in IIM patients remain poorly understood. OLFM4 is overexpressed in several types of tumors, including colorectal, gastric, pancreatic, and ovarian cancers, and its expression has been associated with tumor progression.

Methods

In this study, we used pathological sections from two clinical centers, biopsies of IM tissues, precancerous lesions of gastric cancer (PLGC) cell models, animal models, and organoids to explore the role of OLFM4 in IIM.

Results

Our results show that OLFM4 expression is highly increased in IIM, with superior diagnostic accuracy of IIM when compared to CDX2 and MUC2. OLFM4, along with MYH9, was overexpressed in IM organoids and PLGC animal models. Furthermore, OLFM4, in combination with Myosin heavy chain 9 (MYH9), accelerated the ubiquitination of GSK3β and resulted in increased β-catenin levels through the Wnt signaling pathway, promoting the proliferation and invasion abilities of PLGC cells.

Conclusions

OLFM4 represents a novel biomarker for IIM and could be utilized as an important auxiliary means to delimit the key population for early gastric cancer screening. Finally, our study identifies cell signaling pathways involved in the progression of IM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetaplasiaGlycogen Synthase Kinase 3 betabeta CateninMyosin Heavy ChainsDisease ProgressionHumansAnimalsMiceStomach NeoplasmsFemaleWnt Signaling PathwayCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticDisease Models, AnimalMaleOrganoids

Substanzen

Glycogen Synthase Kinase 3 betabeta CateninMyosin Heavy ChainsMYH9 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping, Shantou, Guangdong, 515041, P.R. China.
  • Department of Gastrointestinal Surgery, Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China.
  • The Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Scientific Research Center, The Biobank, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, Guangdong, P.R. China.
  • Department of Laboratory Medicine, Shenzhen People's Hospital, (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong,…
  • Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping, Shantou, Guangdong, 515041, P.R. China. feiran.z@126.com.

Förderung

  • Guangdong Provincial Key Laboratory of Digestive Cancer Research
  • Guangdong Basic and Applied Basic Research Foundation
  • the Science and Technology Planning Project of Shenzhen Municipality
  • He Yulong Expert Workstation of Yunnan Province
  • Science and Technology Special Project of the National Sustainable Development Agenda Innovation Demonstration Zone of Yunnan Province
  • the National Natural Science Foundation of China

Zitieren

APA

Wei, H., Li, W., Zeng, L., Ding, N., Li, K., Yu, H., Jiang, F., Yin, H., Xia, Y., Deng, C., Cai, N., Chen, X., Gu, L., Chen, H., Zhang, F., He, Y., Li, J., & Zhang, C. (2024). OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway. Molecular Cancer, 23(1). https://doi.org/10.1186/s12943-024-02016-9

Vancouver

Wei H, Li W, Zeng L, Ding N, Li K, Yu H, et al. OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway. Molecular Cancer. 2024;23(1). doi:10.1186/s12943-024-02016-9

BibTeX
@article{Wei2024,
  author = {Wei, Hongfa and Li, Wenchao and Zeng, Leli and Ding, Ni and Li, Kuan and Yu, Hong and Jiang, Fei and Yin, Haofan and Xia, Yu and Deng, Cuncan and Cai, Nan and Chen, Xiancong and Gu, Liang and Chen, Huanjie and Zhang, Feiran and He, Yulong and Li, Jia and Zhang, Changhua},
  title = {OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway},
  journal = {Molecular Cancer},
  year = {2024},
  volume = {23},
  number = {1},
  doi = {10.1186/s12943-024-02016-9}
}
Kostenlos starten →